Dandelion is creating the world’s first Generative Neuromodulation™ platform to treat the brain.
“Enthusiastic on the potential implications of this innovative technology.” National Institutes of Health
NEW
PARADIGM
Most treatments for brain disorders targeting neurochemistry have broad often deleterious effects on neurofunction. At Dandelion, we are developing a platform to program network dynamics in the brain.
News
News
Is there a programming language for the brain? Let’s find out together.
Join our mission by emailing us at careers@dandelion.science
Contact Us
Please contact us if you are interested in partnering or learning more about our work.
Our system has encountered an error. This exception has been automatically logged and reported. RG4FTAHPKJ559ZHAE5TG
Locations
📍Dandelion Science Corp, USA
95 River Street, Suite 5D
Hoboken, NJ, 07030
USA
📍 Dandelion Science Sàrl, Switzerland
Route de la Corniche 8
Epalinges Lausanne, VD, 1066
Switzerland